We believe in integrating the fields of medical research and data science to identify novel and transformative therapies
Success in drug development is contingent on more than just scientific research. Our process focuses on event tracking, clinical trial underwriting, risk management, and a culture rooted in technical diligence and continuous improvement
We strive to integrate complimentary skills across medicine and analytics to develop and test conviction in our investment hypotheses
In forming Logos, we’ve set out to build a community for those passionate to contribute to healthcare. Discovery and innovation takes years. Our strategy centers on identifying transformative biotechnology companies in the discovery, clinical, regulatory, and commercial stage of development.
We believe the fields of medicine and drug development are the pinnacle of cross-disciplinary collaboration. Our culture is founded on a set of complementary skills that leverage multiple frameworks of analysis, from underwriting preclinical toxicology to assessing biomarkers for clinical activity and understanding cell-therapy manufacturing protocols.
We are scientists and physicians at the core, investing in companies working to improve human life and advance promising therapies. We emphasize the importance of experimental design and apply structured approaches to defining and refining our core data analytics platform and clinical simulations.
Complete transparency and alignment with all our partners
To strive for innovation and combat complacency
To reflect objectively and revaluate
To support one another in our journey of continuous improvement
The pursuit of truth in all forms
The Logos Capital team is composed of trained experts in the field of chemistry, engineering, biology, and data science. We committed to supporting true innovation through investing directly in companies pushing the boundaries of medical science and patient care
Arsani William, MD MBA
Chief Investment Officer
Edward Zhong, PhD
Head of Data Science
Yanni Souroutzidis, MBA
Head of Research
Graham Walmsley, MD PhD
Logos Private Portfolio
1 Letterman Drive
Building D, Suite D3-700
San Francisco, CA 94129
+1 (415) 801-4660